Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
Timestops (6)
Tools Used
Topic Overview
Key Takeaways
- Socioeconomic disadvantage significantly increases mortality risk in pediatric Wilms tumor (HR 2.02) and neuroblastoma even after adjusting for clinical factors.
- Social determinants of health impact survival independent of tumor biology, stage, treatment received, and patient comorbidities.
- Median household income and community education level serve as measurable proxies for identifying at-risk pediatric oncology patients.
- Equity gaps in pediatric solid tumor outcomes persist beyond medical interventions and require targeted social support strategies.
- Screening for socioeconomic risk factors should be integrated into pediatric oncology care to improve outcomes for disadvantaged children.
Keywords
Hashtags
Transcript
Here's a tough question we don't talk about enough in pediatric oncology. How much does a child's social factors influence their chance of surviving cancer? Hi, I'm Sophia Schermerhorn, and I'm here to share a study from Cincinnati Children's that addresses this issue. They performed a retrospective study of 12,000 patients with neuroblastoma, Wilms tumor, and hepatoblastoma from the National Cancer Database. Then they made a socioeconomic Economic disadvantage score for each patient based on the median household income and education level in their local communities, and the results were pretty striking. The most disadvantaged kids were more likely to have worse survival for Wilms and neuroblastoma. And when researchers adjusted for tumor size, grade, treatment, and comorbidities, these effects were still present. The hazards ratio of 2.02 for Wilm's tumor and 1.29 for hepatoblastoma. So what does this matter? Pediatric oncology outcomes aren't just about tumor biology or treatment received. It's about the social determinants of health for these children as well. So identifying these risk factors is key if we want to close equity gaps and improve survival for all kids with solid tumors.